1119040

Pillar5 Pharma Inc. — FEI 3000241849

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 21, 2020
Fiscal Year
2020
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Arnprior (Canada)

Citations

IDCFRDescription
145121 CFR 211.113(b)Procedures for sterile drug products